Life Sciences Market-by-Market Analysis
Select each city on the map below to view an in-depth life sciences market summary.
Several global markets have developing life sciences sectors of note. Some of the characteristics these markets share include a growing number of life sciences companies, government initiatives and support, historical sector performance, investment, R&D activities and employment. Read more about emerging life sciences markets.
INTERESTED IN MORE?
Annual rent growth was strong across most markets, growing by double digits in nine of the 15 markets tracked. Vacancy rates remain low in most markets, with nine of the 15 markets falling below 10%.
Life sciences job postings grew across all three major markets, as employers continued to seek talent to fill open positions: U.S. up 30% YoY, Canada up 52% YoY and UK up 15% YoY.
Global life sciences venture capital (VC) funding and initial public offering (IPO) markets experienced a slowdown in 2022. Funding totaled $66.6 billion, down 45% from peak 2021 levels. Read more about Life Sciences Funding in our recent Life Sciences Funding In View article.
Excluding 2021, there were more ongoing trials in 2022 than any other year in the past two decades. Currently, there are approximately 44,500 active clinical trials among the markets tracked by Cushman & Wakefield.